Back to companies
SAB Biotherapeutics, Inc.
SABSUSNASDAQPharmaceuticals & HealthcareSAB Biotherapeutics, Inc.
Revenue
—
FY2025
Operating income
-$49.0mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API